Growth hormone is a secretory product of some primary bronchial neoplasms and has been associated with the development of hypertrophic pulmonary osteoarthropathy and acromegaly in occasional patients with such tumours; it has not, however, generally been considered important in the pathogenesis of digital clubbing. Plasma levels of growth hormone at the time of diagnostic bronchoscopy were measured in 60 patients with histologically proved bronchial carcinoma, divided according to whether clubbing was present (n = 21) or absent (n = 39), and in 13 control subjects undergoing the same procedure but with no neoplasm. The median plasma level of growth hormone (and interquartile range) was 0 74 (0-5-10) mUll in five control subjects with no pulmonary disease, 0-83 (0-41-3) mU/l in eight subjects with non-neoplastic pulmonary disease, 1-1 (0 6-3 3) mUll in patients with carcinoma but without clubbing, and 3-1 (08-9 0) mUll in 21 patients with carcinoma and clubbing. The highest growth hormone level was seen in a patient with a small cell carcinoma and pronounced clubbing; levels had fallen to normal by the time chemotherapy was completed and clubbing completely resolved. Thus growth hormone or a similar substance might have a role in the pathogenesis of clubbing in patients with bronchial neoplasms.
Clubbing of the fingers and toes depends on expansion of the soft tissues around the terminal phalanges due to vasodilatation, and an increase in vascular connective tissue. ' Results The mean and-interquartile range of plasma growth hormone levels for control subjects and patients with bronchial carcinoma are shown in table 1. The eight subjects with non-neoplastic pulmonary disease had chronic bronchitis (4), pneumonia (3), and pulmonary fibrosis (1). Growth hormone plasma levels are shown according to histological tumour type in table 2 and in the figure.
There were significant differences in plasma growth hormone levels between control subjects and the two groups of patients with carcinoma (p = 0003) that were unrelated to tumour type (p = 0-21). Of the 10 subjects with the highest growth hormone levels, seven had clubbing and six had a small cell carcinoma. There was no correlation between plasma growth hormone levels and metastatic disease (p = 0 29). Immunochemical examination failed to show immunoreactive growth hormone in the biopsy tissue of any patient.
The highest level of growth hormone (24-0 mU/l) was found in a 63 year old woman with a small cell carcinoma and no evidence of metastasis. She had pronounced clubbing of all fingers and toes at the time of diagnosis. Her plasma growth hormone had fallen to 9,0 mU/l after three cycles of chemotherapy and to 2-0 mU/l after the full course of six cycles. Repeat bronchoscopy at this time, seven months after diagnosis, showed no evidence of residual disease and her clubbing had completely resolved. She remains well with no recurrence of carcinoma or clubbing 18 months after diagnosis.
Discussion
This paper describes an association between plasma growth hormone concentrations and clubbing in patients with bronchial carcinoma. Raised levels of growth hormone and a paradoxical rise in its concentration after administration ofglucose have been reported in patients with bronchial tumours,"' but the cause of these phenomena has remained obscure.
Stress is unlikely to be responsible. Great care was taken in this study to ensure that all patients were approached and examined in exactly the same way and values in control subjects were within the normal range and showed little scatter (table 1 and figure) . Nor can the results be explained by the presence of metastatic disease as no significant correlation was found. Andrews showed that plasma growth hormone concentrations in patients with primary and metastatic carcinoma were significantly higher when deposits were present in the liver than when they were absent or in other organs and were independent of the site of the primary tumour. 13 We do not believe that dissemination to the liver can explain the raised levels in our patients. Although not all were specifically investigated for liver metastases, ultrasound and radioisotope scanning of the liver were performed in two patients with high growth hormone concentrations and clubbing and no metastases were found. There is no 16 A role for a growth hormone like substance has often been A implied4 but it might be one of several factors and may act synergistically with other factors. If growth hormone is being secreted in excess in some patients with bronchial carcinoma, there are three likely sources. It has been found in bronchial tumours'7 18 and as a product of bronchial carcinoma cell lines in culture. '9 We did not find growth hormone in the biopsy tissue from our patients, but the samples were small and may be unrepresentative. Alternative sources include the surrounding lung20 and possibly the pituitary after its stimulation by growth hormone releasing hormone like substances from the tumour or surrounding lung.2' 22 Further studies are needed to clarify the relation between bronchial carcinoma, growth hormone, and clubbing.
